- Tuesday, October 29, 2024 @ 12:00 am
LubioScience GmbH, Switzerland’s leading life science distributor, has partnered with Zymo Research to bring specialized Next-Generation Sequencing (NGS) services for epigenetics and microbiomics to the Swiss market. This collaboration enables Swiss biotech companies to obtain reliable NGS data with faster turnaround times and highly competitive pricing.
Partnering with Zymo Research, LubioScience offers NGS service solutions tailored to the needs of Swiss biotechs making advanced NGS analysis accessible to all researchers.
Founded in California in 1994, Zymo Research has led the way in molecular biology, with innovative products in DNA, RNA, and epigenetics research. Known for simplifying complex workflows and delivering consistent, high-quality results, Zymo Research is trusted by both academic and biopharmaceutical researchers worldwide. Their services include end-to-end solutions, custom workflows, and cutting-edge bioinformatics, all delivered through state-of-the-art sample processing with highly competitive pricing. NGS services are conducted in Frankfurt, Germany, or Irvine, California, with state-of-the-art data security protocols covering all aspects - from infrastructure and processes to storage and delivery.
“We are thrilled to collaborate with Zymo Research to provide Swiss researchers access to their highly-regarded NGS services,” said Dr. Muriel Revol, Managing Director of LubioScience. “This partnership is a testament to our shared commitment to advancing science through reliable and accessible solutions.”
Through this partnership, Swiss biotech association members will enjoy exclusive special conditions, making world-class NGS solutions more affordable and accessible.
